These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36477672)

  • 1. Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy-an observational follow-up study.
    Boros KK; Veres G; Cseprekál O; Pintér HK; Richter É; Cseh Á; Dezsőfi-Gottl A; Arató A; Reusz G; Dohos D; Müller KE
    Eur J Clin Nutr; 2023 Mar; 77(3):380-385. PubMed ID: 36477672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.
    Li J; Liu Z; Hu P; Wen Z; Cao Q; Zou X; Chen Y; Wang Y; Zhong J; Shen X; Demuth D; Fadeeva O; Xie L; Chen J; Qian J
    BMC Gastroenterol; 2022 Feb; 22(1):44. PubMed ID: 35120446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of body muscle mass as an indicator of activity in inflammatory bowel disease patients.
    Zalizko P; Roshofa TH; Meija L; Bodnieks E; Pukitis A
    Clin Nutr ESPEN; 2020 Dec; 40():193-200. PubMed ID: 33183536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population.
    Lee GW; Chew KS; Wong SY; Chong SY; Ong SY; Lee WS
    J Paediatr Child Health; 2022 Nov; 58(11):1972-1979. PubMed ID: 35880617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.
    Severs M; Mangen MJ; van der Valk ME; Fidder HH; Dijkstra G; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Vermeijden JR; van der Meulen-de Jong AE; Pierik M; Siersema PD; Oldenburg B;
    J Crohns Colitis; 2017 Mar; 11(3):342-352. PubMed ID: 27647859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease.
    Singh A; Midha V; Mahajan R; Verma S; Kakkar C; Grover J; Singh D; Kaur R; Masih A; Bansal N; Wall C; Sood A
    Dig Dis Sci; 2023 Feb; 68(2):580-595. PubMed ID: 36064826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional status and food intake in pediatric patients with inflammatory bowel disease at diagnosis significantly differs from healthy controls.
    Sila S; Trivić I; Pavić AM; Niseteo T; Kolaček S; Hojsak I
    Eur J Pediatr; 2019 Oct; 178(10):1519-1527. PubMed ID: 31422462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioelectrical Impedance Phase Angle as an Indicator of Malnutrition in Hospitalized Children with Diagnosed Inflammatory Bowel Diseases-A Case Control Study.
    Więch P; Dąbrowski M; Bazaliński D; Sałacińska I; Korczowski B; Binkowska-Bury M
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29673210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study.
    El-Matary W; Leung S; Tennakoon A; Benchimol EI; Bernstein CN; Targownik LE
    Inflamm Bowel Dis; 2020 Jan; 26(1):134-138. PubMed ID: 31323083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional Status and Its Detection in Patients with Inflammatory Bowel Diseases.
    Jabłońska B; Mrowiec S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the GLIM criteria for diagnosis of malnutrition and quality of life in patients with inflammatory bowel disease: A multicenter, prospective, observational study.
    Zhang Y; Zhang L; Gao X; Dai C; Huang Y; Wu Y; Zhou W; Cao Q; Jing X; Jiang H; Zhu W; Wang X
    Clin Nutr; 2022 Jun; 41(6):1297-1306. PubMed ID: 35537380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
    Mader O; Juillerat P; Biedermann L; Michetti P; Hruz P; Pittet V; Rogler G; Zahnd-Straumann N; Seibold F
    United European Gastroenterol J; 2021 Apr; 9(3):398-406. PubMed ID: 33203339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.